Symbol
CLLS on Nasdaq
Investment type
Equity / Ordinary Shares, nominal value EUR0.05 per share
Latest Disclosed Shares Owned
44,000,000 shares
Security Ownership %
44%

AstraZeneca PLC ownership in Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS)

24 Jan 2025 - AstraZeneca PLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 44,000,000 shares of Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS). This represents 44% ownership of the company. This is the first filing by ASTRAZENECA PLC disclosing ownership of Cellectis S.A. Ordinary Shares, nominal value EUR0.05 per share (CLLS).